Ginkgo Bioworks Holdings, Inc. (DNA) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 460.85M |
| Enterprise Value | 733.54M |
| P/E Ratio | -2.85 |
| PEG Ratio | -0.07 |
| Price/Sales Ratio | 8.03 |
| Price/Book Ratio | 1.96 |
| Enterprise/Revenue | 11.13 |
| Enterprise/EBITDA | -5.18 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -2.49 |
| Operating Margin | -2.43 |
| Return On Assets | -0.27 |
| Return On Equity | -0.57 |
| Revenue | 170.16M |
| Revenue/Share | 1.57 |
| Gross Profit | 138.63M |
| EBITDA | -254.61M |
| Net Income | -312.76M |
| Diluted EPS | -5.64 |
| Total Cash | 285.36M |
| Total Cash/Share | 4.46 |
| Total Debt | 397.2M |
| Total Debt/Equity | 1.01 |
| Current Ratio | 4.72 |
| Book Value Per Share | 6.14 |
| 52-Week Change | 41.96 |
| 52-Week High | 18.22 |
| 52-Week Low | 5.37 |
| Moving Average 50 Days | 10 |
| Moving Average 200 Days | 8.62 |
| Average Volume | 2.37M |
| Shares Outstanding | 67.34M |
| % Held by Institutions | 61.42 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
| Last Split Date | August 20, 2024 |